You are here

  • Home
  • Archive
  • Volume 79, Issue 9
  • Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone

Article metrics

Article menu
Download PDFPDF
Letter
Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone

 

Online download statistics by month:

Online download statistics by month: May 2020 to March 2024

AbstractFullPdf
May 2020113118565
Jun 20205483717
Jul 20201712813
Aug 20204694526
Sep 20203794029
Oct 2020139268
Nov 20201281816
Dec 2020153199
Jan 2021128147
Feb 20211161410
Mar 20214374
Apr 20212751411
May 202143109
Jun 20211395
Jul 20211591
Aug 20211355
Sep 20211366
Oct 2021260324
Nov 20217623
Dec 202184130
Jan 20226055
Feb 20227485
Mar 20229031
Apr 20226481
May 20228533
Jun 202211763
Jul 20226751
Aug 20227883
Sep 20228663
Oct 20226641
Nov 20226634
Dec 20224332
Jan 20233951
Feb 20239333
Mar 20232561
Apr 20232810
May 20233301
Jun 20231311
Jul 20233353
Aug 20232572
Sep 20235263
Oct 202310863
Nov 20234140
Dec 20239076
Jan 20244148
Feb 20242531
Mar 20244322
Total5782655315